New spray prevents deadly antibiotic-resistance infections for up to ... - Study Finds

GOTHENBURG, Sweden — Scientists with the World Health Organization (WHO) consider antibiotic resistance one of the top ten threats to public health. Although certain strains of bacteria continue build up a tolerance to various medications, researchers from Chalmers University of Technology are developing a new spray that not only works for wound care and other medical practices, but also kills antibiotic-resistant bacteria.

"Our innovation can have a dual impact in the fight against antibiotic resistance. The material has been shown to be effective against many different types of bacteria, including those that are resistant to antibiotics, such as Methicillin-resistant Staphylococcus aureus (MRSA), while also having the potential to prevent infections and thus reduce the need for antibiotics," says Martin Andersson, head of research for the study and professor at the Department of Chemistry and Chemical Engineering at Chalmers, in a university release.

Currently, estimates show that antibiotic-resistance causes nearly 1.3 million deaths per year around the world. In an effort to mitigate the effects of these bacteria, Chalmers scientists built a material with small hydrogel particles that contain a peptide (a type of protein) capable of binding to and killing harmful bacteria. This attachment allows for particles to provide a protective environment and help keep the peptides stable. Normally, fluids in the body like blood could deactivate these peptides and render them nearly unusable in healthcare. Previously, the team has shown the great potential of this work when it comes to wound care, but now their new studies show that it can reach new heights, and without adverse effects.

"The substance in this wound spray is completely non-toxic and does not affect human cells. Unlike existing bactericidal sprays, it does not inhibit the body's healing process. The materials, which are simply sprayed onto the wound, can also kill the bacteria in a shorter time," says study lead author Edvin Blomstrand, an industrial doctoral student at the Department of Chemistry and Chemical Engineering at Chalmers University of Technology.

The spray could reduce the side-effects of using surgical implants

The substance tackles the other huge issue of infection risk, which is very common with surgical implants and catheter insertions into the body. Since these procedures are so common, it's necessary for antibacterial biomaterials such as materials that treat, replace, or modify organs or other bodily tissues to be readily available. In the hospital setting, urinary catheters, which help patients drain urine from their bladder, are primary sources of infection. The teams' new project could help reduce the risk and even prevent this.

"Although the catheters are sterile when unpacked, they can become contaminated with bacteria while they are being introduced into the body, which can lead to infection. One major advantage of this coating is that the bacteria are killed as soon as they come into contact with the surface. Another is that it can be applied to existing products that are already used in healthcare, so it is not necessary to produce new ones," says co-lead author Annija Stepulane, a doctoral student at the Department of Chemistry and Chemical Engineering at Chalmers.

So far, the team has shown that the material can kill 99.9 percent of bacteria and that the ability to kill bacteria can last for 48 hours, allowing for versatile use in clinical settings. The researchers continue to collaborate with others in the world of biotechnology to soon commercialize the product.

The findings are published in the Journal of Pharmaceutics

YouTube video

Adblock test (Why?)

Comments

Post a Comment

Popular posts from this blog

Rashes that look like scabies: Causes, symptoms, and treatment - Medical News Today

Image
Scabies is a skin condition that occurs as the result of a mite known as Sarcoptes scabiei. The rash that results from scabies may appear similar to other skin conditions, such as psoriasis, eczema, or contact dermatitis. In this article, we look at what a scabies rash looks like. We also look at other rashes that are similar in appearance and their treatment options. Scabies is a common condition that occurs as the result of an infestation of a microscopic skin mite called Sarcoptes scabiei. The mites burrow under the skin, causing intense itching and a rash. The Centers for Disease Control and Prevention (CDC) describes the rash as pimple-like. On darker skin, the rash may be more difficult to see, but a person should be able to feel it. According to DermNet, a scabies rash is varied in appearance, and may appear as: pimple-like on the limbs and trunk widespread or coin-shaped small blisters scales lesions in the armpits, groin, navel, areolas, scrotum, buttocks, and along the penil...
Read more

Urinary Tract Infection (UTI): Causes, Symptoms & Treatment - Cleveland Clinic

Image
Can I prevent a urinary tract infection? The following lifestyle changes can help prevent urinary tract infections: Practice good hygiene Practicing good hygiene is one of the best ways to help prevent UTIs. This is especially important if you have a vagina because your urethra is much shorter, and it's easier for E. coli to move from your rectum back into your body. Always wipe from front to back after a bowel movement (pooping) to avoid this. During your menstrual cycle, it's also a good idea to regularly change your period products, including pads and tampons. You should also avoid using any deodorants on your vagina. Drink plenty of fluids Drinking extra fluids — especially water — each day can help flush out bacteria from your urinary tract. Healthcare providers recommend drinking six to eight glasses of water daily. Change your peeing habits Peeing can play a big role in getting rid of bacteria from your body. Your pee is a waste product, and each time you empty your bla...
Read more

Symtuza: Uses, side effects, alternatives, and more - Medical News Today

Image
The Food and Drug Administration (FDA) approves prescription drugs such as Symtuza to treat certain conditions. Symtuza is FDA-approved to treat HIV-1 in adults and children who weigh at least 40 kilograms (kg), which is about 88 pounds (lb). It's approved for people who: have just been diagnosed with HIV and haven't started treatment yet, OR are changing from another HIV treatment and: have been on a stable antiretroviral regimen for at least 6 months (this means you haven't had any changes to your HIV drugs for at least 6 months) have a viral load (the amount of HIV in your blood) that's less than 50 copies per milliliter (mL) have HIV that doesn't have mutations (changes) that could make it resistant (less likely to respond) to darunavir or tenofovir (two of the active drugs in Symtuza) HIV explained HIV stands for human immunodeficiency virus. There are two forms of this virus, HIV-1 and HIV-2. HIV-1 is the most common form. HIV is transmitted through body fluid...
Read more